References
- Axelrod J, Burch RM, Jelsema CL. 1988. Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: Arachidonic acid and its metabolites as second messengers. Trends Neurosci 11:117–123.
- Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V. 2001. Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci USA 98:6402–6406.
- Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gangadharan U, Hobbs C, Di Marzo V, Doherty P. 2003. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163:463–468.
- Devane WA, Dysarz FA III, Johnson MR, Melvin LS, Howlett AC. 1988. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605–613.
- Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D. 2002. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99:10819–10824. Giang DK, Cravatt BF. 1997. Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci USA 94:2238–2242.
- Goparaju SK, Ueda N, Yamaguchi H, Yamamoto S. 1998. Anandamide amidohydrolase reacting with 2-arachidonoylgly- cerol, another cannabinoid receptor ligand. FEBS Lett 422: 69–73.
- Hansen HS, Lauritzen L, Moesgaard B, Strand AM, Hansen HH. 1998. Formation of N-acyl-phosphatidylethanolamines and N- acetylethanolamines: Proposed role in neurotoxicity. Biochem Pharmacol 55:719–725.
- Hwang SC, Jhon DY, Bae YS, Kim JH, Rhee SG. 1996. Activation of phospholipase C-gamma by the concerted action of tau proteins and arachidonic acid. J Biol Chem 271:18342–18349.
- Karpe F, Wejde J, Anggard E. 1984. Dietary arachidonic acid protects mice against the fatty liver induced by a high fat diet and by ethanol. Acta Pharmacol Toxicol 55:95–99.
- McAllister SD, Glass M. 2002. CB(1) and CB(2) receptor- mediated signalling: A focus on endocannabinoids. Prostaglandins Leukot Essent Fatty Acids 66:161–171.
- Mechoulam R, Hanus L, Martin BR. 1994. Search for endogenous ligands of the cannabinoid receptor. Biochem Pharmacol 48: 1537– 1544.
- Okaichi Y, Ishikura Y, Akimoto K, Kawashima H, Toyoda-Ono Y, Kiso Y, Okaichi H. 2005. Arachidonic acid improves aged rats’ spatial cognition. Physiol Behav 84:617–623.
- Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N. 2004. Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279:5298–5305.
- Romero J, Garcia L, Fernandez-Ruiz JJ, Cebeira M, Ramos JA. 1995. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Pharmacol Biochem Behav 51: 731–737.
- Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 1995. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89–97.
- Sun GY, Horrocks LA. 1970. The acyl and alk-1-enyl groups of the major phosphoglycerides from ox brain myelin and mouse brain microsomal, mitochondrial and myelin fractions. Lipids 5: 1006–1012.
- Ueda N, Kurahashi Y, Yamamoto S, Tokunaga T. 1995. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J Biol Chem 270: 23823–23827.
- Ueda N, Puffenbarger RA, Yamamoto S, Deutsch DG. 2000. The fatty acid amide hydrolase (FAAH). Chem Phys Lipids 108: 107–121.
- Watanabe S, Doshi M, Hamazaki T. 2003. n— 3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n— 3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot Essent Fatty Acids 69:51–59.